Genetic Modifiers of VWF Cleavage by ADAMTS13

被引：0
|
作者：
Zhou, Wenhua [1 ,3 ]
Tsai, Han-Mou [2 ,3 ]
机构：
[1] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[2] Duke Univ, Med Ctr, Div Hematol, Durham, NC USA
[3] Albert Einstein Coll Med, Montefiore Med Ctr, Div Hematol, Bronx, NY 10467 USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [31] High VWF, low ADAMTS13 puts women at risk
    Bender, Markus
    BLOOD, 2012, 119 (06) : 1329 - 1330
  • [32] How ADAMTS13 recognises and cleaves the VWF scissile bond
    Lane, D. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 6 - 6
  • [33] GENETIC VARIATION IN ADAMTS13 ARE RELATED TO VWF LEVELS, ATRIAL FIBRILLATION AND CEREBRAL ISCHEMIC EVENTS
    Warlo, E. M. K.
    Bratseth, V.
    Pettersen, A. -A. R.
    Arnesen, H.
    Seljeflot, I.
    Opstad, T. B.
    ATHEROSCLEROSIS, 2022, 355 : E277 - E277
  • [34] Genetic Variation in ADAMTS13 is Related to VWF Levels, Atrial Fibrillation and Cerebral Ischemic Events
    Warlo, Ellen M. K.
    Bratseth, Vibeke
    Pettersen, Alf-Age R.
    Holme, Pal Andre
    Arnesen, Harald
    Seljeflot, Ingebjorg
    Opstad, Trine B. B.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [35] Genetic Variation in ADAMTS13 is Related to VWF Levels, Atrial Fibrillation and Cerebral Ischemic Events
    Warlo, Ellen M. K.
    Bratseth, Vibeke
    Pettersen, Alf-Age R.
    Holme, Pal Andre
    Arnesen, Harald
    Seljeflot, Ingebjorg
    Opstad, Trine B.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [36] Genetic Variation in ADAMTS13 is Related to VWF Levels, Atrial Fibrillation and Cerebral Ischemic Events
    Warlo, Ellen M. K.
    Bratseth, Vibeke
    Pettersen, Alf-age R.
    Holme, Pal Andre
    Arnesen, Harald
    Seljeflot, Ingebjorg
    Opstad, Trine B.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [37] Genetic variants in ADAMTS13 as well as smoking are major determinants of plasma ADAMTS13 levels
    Ma, Qianyi
    Jacobi, Paula M.
    Emmer, Brian T.
    Kretz, Colin A.
    Ozel, Ayse Bilge
    McGee, Beth
    Kimchi-Sarfaty, Chava
    Ginsburg, David
    Li, Jun Z.
    Desch, Karl C.
    BLOOD ADVANCES, 2017, 1 (15) : 1037 - 1046
  • [38] ADAMTS13 in nephrology [ADAMTS13 in der Nephrologie]
    Bockmeyer C.L.
    Modde F.
    Becker J.U.
    Der Nephrologe, 2013, 8 (1): : 69 - 70
  • [39] Cleavage of the ADAMTS13 propeptide is not required for protease activity
    Majerus, EM
    Zheng, XL
    Tuley, EA
    Sadler, JE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (47) : 46643 - 46648
  • [40] Cleavage of ADAMTS13 propeptide is not required for activity.
    Majerus, EM
    Zheng, XL
    Tuley, EA
    Sadler, JE
    BLOOD, 2003, 102 (11) : 780A - 780A
12345